Skip to main content
Medical information Clinical review pending

Genetic Testing

Pan Enteric Bacteria RNA Detection Qualitative Test

Detects RNA from common enteric viruses causing gastrointestinal illness. Helps identify the cause of symptoms like severe diarrhea, vomiting, and abdominal pain.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Sample types may include whole blood, rectal swabs, food, or water samples. Confirm the required specimen type with the laboratory before booking.
Results
Results are typically available within 24-36 hours. Confirm exact turnaround time with the laboratory.
Preparation
No specific preparation is required for this test. Please ensure you have signed the consent document and can provide relevant clinical history.
Test priceKSh 9,520

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Pan Enteric Bacteria RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Severe or persistent diarrhea
  • ✓Vomiting
  • ✓Abdominal pain
  • ✓Fever accompanied by gastrointestinal symptoms
  • ✓Suspected outbreak of gastrointestinal illness
  • ✓Recent travel to areas with known viral outbreaks
  • ✓Immunocompromised individuals with gastrointestinal symptoms
02

In plain language

What this test helps you understand

This test helps identify the presence of RNA from common enteric viruses. It can aid in diagnosing viral gastroenteritis, especially when symptoms are severe or prolonged. Identifying the specific virus may inform treatment decisions and public health measures.
The Pan Enteric Bacteria RNA Detection Qualitative Test is a diagnostic procedure used to identify the presence of RNA from specific enteric viruses. These viruses are common causes of gastrointestinal infections. This test is particularly useful for individuals experiencing symptoms suggestive of a viral gastrointestinal illness. It utilizes advanced molecular techniques to detect viral genetic material in patient samples. Understanding the specific virus causing the illness can help guide appropriate medical management and prevent further spread. This test is available at DNA Labs Kenya locations.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific preparation is required for this test. Please ensure you have signed the consent document and can provide relevant clinical history.
SampleSample types may include whole blood, rectal swabs, food, or water samples. Confirm the required specimen type with the laboratory before booking.
MethodologyThe test utilizes Real Time PCR (Polymerase Chain Reaction) technology to detect and quantify viral RNA.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects RNA from specific enteric viruses. It may not detect all possible causes of gastrointestinal illness, such as bacterial infections or non-infectious causes. The sensitivity and specificity of the test depend on the sample quality and the viral load.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the RNA (genetic material) of common enteric viruses known to cause gastrointestinal illnesses.
Identifying the specific virus causing symptoms can help doctors provide appropriate care and manage the spread of infection.
The required sample type can vary and may include whole blood, rectal swabs, food, or water. Please confirm with the lab before your visit.
Results are generally available within 24-36 hours. Please confirm the specific turnaround time with the laboratory.
It is important to discuss your test results with your healthcare provider to understand their meaning and any necessary follow-up steps.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp